Strategy
Page 1 • 2 itemsUnlock global pharma market insights. NovaPharmaNews delivers strategic intelligence for investors, BD, and analysts to drive pharmaceutical growth.
PMDA SAKIGAKE Designation: Expediting Drug Approval in Japan
The PMDA SAKIGAKE Designation streamlines the approval process for drugs like XYZ, enhancing access to innovative therapies for patients in Japan.
NMPA Accelerated Drug Approvals: Key Policy Changes & Market Impact
Explore the recent NMPA policy changes on accelerated drug approvals and their significant impact on the market, particularly for treatments like XYZ Drug for cancer.